V-CARD

PHONE
+1 202 637 3648
FAX
+1 202 637 5910
|
|
Leigh
L.
Oliver
Associate, Washington, D.C.
leigh.oliver@hoganlovells.com
Leigh Oliver's practice is entirely devoted to antitrust and trade regulation law, including counseling and litigation on a wide range of competition and policy issues, including mergers and acquisitions, joint ventures, the Robinson-Patman Act, the Sherman Act, the Clayton Act, and the FTC Act. Leigh has extensive experience working on government investigations into prospective and post-consummated mergers and acquisitions, as well as responding to non-merger government investigations. She has represented clients from a variety of industries, including healthcare, life sciences, energy, entertainment and defense, before the Federal Trade Commission, the Antitrust Division of the U.S. Department of Justice, and various state attorneys general. She is the Young Lawyer Representative on the ABA Antitrust Section's Federal Civil Enforcement Committee. Leigh received a B.A. from Haverford College and a J.D., magna cum laude, from The Catholic University of America.
While in law school, Leigh was the executive editor of The Catholic University Law Review and a research assistant to Dean Douglas Kmiec and Reverend Raymond O'Brien.
REPRESENTATIVE EXPERIENCE
Counsel to Laboratory Corporation of America in defense of a challenge from the FTC relating to the acquisition of certain assets of Westcliff Medical Laboratories.
Antitrust counsel to The Black & Decker Corporation in its merger with The Stanley Works.
Counsel to Paciolan, Inc. in its acquisition by Ticketmaster Corp.
Counsel to Genzyme in its transaction with Bayer involving Campath.
Antitrust counsel to General Dynamics Corporation in multiple defense industry transactions.
Counsel to a major health insurer in the sale of its pharmacy benefit management business to a strategic buyer.
Hogan Lovells Publications
08 December 2011
"Life Sciences Antitrust and Competition Newsletter." Life Sciences: Competition & Antitrust Alert, Issue 18, Hogan Lovells
11 July 2011
"Antitrust agencies announce significant changes to the HSR form." Antitrust, Competition and Economic Regulation Alert, Hogan Lovells
02 December 2010
"Life Sciences: Competition and Antitrust Newsletter, Issue 17.", Hogan Lovells
23 July 2010
"Life Sciences: Competition and Antitrust Alert, Issue 16." Competition and Antitrust Alert, Hogan Lovells
11 March 2010
"Life Sciences: Competition Antitrust Update, Issue 15." Life Sciences: Competition Antitrust Update, Hogan & Hartson LLP
27 March 2009
"Life Sciences: Competition & Antitrust Update: Issue 12." Life Sciences: Competition & Antitrust Update, Hogan & Hartson LLP
|
|
|